Yuan-Liang Wen, PhD student

MS
National Defense Medical Center, Taiwan (Republic of China)

I am Wen YuanLiang, currently based in Taiwan, studying in the Ph.D. program of the Department of Life Sciences at the National Defense Medical Center in Taipei City. I am currently a second-year Ph.D. student with a strong passion for pharmacoepidemiology. My research areas are also closely related to pharmacoepidemiology.

Poster(s):

• (016) Hormone Therapy and Risk of Psoriasis in Reproductive and Postmenopausal Women: A Nationwide Cohort Study in Taiwan
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (018) Impact of Immune Checkpoint Inhibitors on Psoriasis Incidence: Emulation of a Randomized Target Trial Using Real-world Data
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (046) Effect of SGLT2 Inhibitors on Decreasing the Risk of Depression in Patients with Diabetes: A Nationwide Active-Comparator Cohort Study in Taiwan
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (061) Healthcare Utilization among Cancer Patients Treated with Immune Checkpoint Inhibitors in Taiwan
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (211) Agomelatine and Inverse Risk of Hypertension, Diabetes and Hyperlipidemia: A Nationwide Active-comparator Study
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (217) 5-alpha Reductase Inhibitors and Effects on Auditory System in Taiwan
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (303) Benzodiazepine receptor agonists and increased risk of sudden sensorineural hearing loss
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (CSPOT50) No Elevated Risk of Cataract in Amiodarone Users: A Population-based Active-Comparator Study
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST